Peer Review History: The Prophylactic Treatment of COVID-19 in a Renal Failure and Hodgkin Lymphoma Patient with Convalescent Plasma

Editor(s):

(1) Dr. Jianxiang (Jason) Chi, Head of Molecular Haematology Laboratory / Head of CytoGenomics Laboratory, The Center for the study of  haematological malignancies (CSHM), Karaiskakio Foundation,  Cyprus

(2) Dr. Juan Carlos Troiano, Professor, School of Veterinary Medicine, University of Buenos Aires, Buenos Aires, Argentina.

(3) Dr. Dharmesh Chandra Sharma, ABTO (Associate Blood Transfusion Officer), G. R. Medical College & J. A. Hospital, Gwalior India

Reviewers:

(1)  Bhanu K. Patibandla, Oregon Health & Science University, USA.

(2)  Rubina Naqvi, Sindh Institute of Urology and Transplantation, Karachi, Pakistan.

(3)  Darapaneni Vivek, Anvek Institute of Biomolecular Research, India.

(4)  Zebene Mekonnen Assefa , Wolkite University, Ethiopia .

(5) Raji Queen Chidinma , Redeemers college of Technology and Management, Nigeria.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.8/10

Average Peer review marks at publication stage: 9.5/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Bhanu K. Patibandla, USA) | File 1 | NA


Stage 2 | Peer review report_2 (Rubina Naqvi, Pakistan) | File 1 | NA


Stage 2 | Peer review report_3 (Darapaneni Vivek, India) | File 1 | NA


Stage 2 | Peer review report_4 (Zebene Mekonnen Assefa, Ethiopia) | File 1 | NA


Stage 2 | Peer review report_5 (Raji Queen Chidinma, Nigeria) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Stage 3 | Comment_Editor_3_v1 | File 1 | NA